These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16517021)

  • 1. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
    Rodrigo R; Felipo V
    Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex of patients with liver cirrhosis.
    Rodrigo R; Erceg S; Felipo V
    Neurobiol Dis; 2005; 19(1-2):150-61. PubMed ID: 15837570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
    Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
    Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile duct ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients.
    Rodrigo R; Jover R; Candela A; Compañ A; Sáez-Valero J; Erceg S; Felipo V
    Neuroscience; 2005; 130(2):435-43. PubMed ID: 15664700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
    J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients.
    Corbalán R; Chatauret N; Behrends S; Butterworth RF; Felipo V
    Hepatology; 2002 Nov; 36(5):1155-62. PubMed ID: 12395325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis.
    Monfort P; Corbalán R; Martinez L; López-Talavera J; Córdoba J; Felipo V
    Neuroscience; 2001; 104(4):1119-25. PubMed ID: 11457595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate-induced activation of nitric oxide synthase is impaired in cerebral cortex in vivo in rats with chronic liver failure.
    Rodrigo R; Erceg S; Rodriguez-Diaz J; Saez-Valero J; Piedrafita B; Suarez I; Felipo V
    J Neurochem; 2007 Jul; 102(1):51-64. PubMed ID: 17286583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
    Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
    Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease.
    Corbalán R; Montoliu C; Miñana MD; Del Olmo JA; Serra MA; Aparisi L; Rodrigo JM; Felipo V
    Metab Brain Dis; 2002 Dec; 17(4):295-301. PubMed ID: 12602506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum.
    Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V
    J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
    Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
    Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Protein Kinase A Modulates Intracellular Calcium/Calmodulin-Dependent Protein Kinase II, Nitric Oxide Synthase, and the Glutamate-Nitric Oxide-cGMP Pathway in Cerebellum. Differential Effects in Hyperammonemia.
    Cabrera-Pastor A; Llansola M; Felipo V
    ACS Chem Neurosci; 2016 Dec; 7(12):1753-1759. PubMed ID: 27673574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
    Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
    Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hyperammonemia in rats impairs activation of soluble guanylate cyclase in neurons and in lymphocytes: a putative peripheral marker for neurological alterations.
    Miñana MD; Corbalán R; Montoliu C; Teng CM; Felipo V
    Biochem Biophys Res Commun; 1999 Apr; 257(2):405-9. PubMed ID: 10198226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo.
    Cabrera-Pastor A; Taoro-Gonzalez L; Felipo V
    J Neurochem; 2016 May; 137(4):539-48. PubMed ID: 26875688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
    Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
    Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats.
    Germoush MO; Othman SI; Al-Qaraawi MA; Al-Harbi HM; Hussein OE; Al-Basher G; Alotaibi MF; Elgebaly HA; Sandhu MA; Allam AA; Mahmoud AM
    Biomed Pharmacother; 2018 Jun; 102():392-402. PubMed ID: 29573618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polychlorinated biphenyls PCB 52, PCB 180, and PCB 138 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms.
    Llansola M; Montoliu C; Boix J; Felipo V
    Chem Res Toxicol; 2010 Apr; 23(4):813-20. PubMed ID: 20297801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
    Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
    Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.